AYAL Capital Advisors Ltd acquired a new position in Amrize Ltd (NYSE:AMRZ – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 110,000 shares of the company’s stock, valued at approximately $5,450,000. Amrize comprises approximately 1.3% of AYAL Capital Advisors Ltd’s investment portfolio, making the stock its 18th largest position.
Several other large investors have also recently bought and sold shares of the company. Groupe la Francaise acquired a new stake in shares of Amrize in the 2nd quarter valued at $60,000. Allianz SE acquired a new position in shares of Amrize during the second quarter valued at $80,000. Credit Industriel ET Commercial bought a new position in Amrize in the second quarter valued at about $109,000. Westerkirk Capital Inc. bought a new position in Amrize in the second quarter valued at about $134,000. Finally, M&T Bank Corp acquired a new stake in Amrize in the second quarter worth about $205,000.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on AMRZ. JPMorgan Chase & Co. upped their target price on shares of Amrize from $52.00 to $60.00 and gave the company an “overweight” rating in a research report on Tuesday, August 26th. Zacks Research upgraded shares of Amrize from a “strong sell” rating to a “hold” rating in a report on Friday, October 10th. Royal Bank Of Canada cut shares of Amrize from an “outperform” rating to a “sector perform” rating and raised their price objective for the company from $56.00 to $60.00 in a research note on Monday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amrize in a report on Thursday, October 30th. Finally, Stephens started coverage on shares of Amrize in a research report on Friday, November 14th. They set an “overweight” rating and a $60.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $59.00.
Insiders Place Their Bets
In related news, CTO Roald Brouwer purchased 4,000 shares of Amrize stock in a transaction dated Friday, October 31st. The stock was bought at an average price of $51.77 per share, for a total transaction of $207,080.00. Following the completion of the acquisition, the chief technology officer directly owned 9,000 shares of the company’s stock, valued at $465,930. This represents a 80.00% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jaime Hill acquired 4,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 4th. The shares were bought at an average price of $50.69 per share, for a total transaction of $202,760.00. Following the completion of the acquisition, the insider owned 18,101 shares of the company’s stock, valued at $917,539.69. This trade represents a 28.37% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 65,000 shares of company stock valued at $3,399,720 over the last 90 days.
Amrize Stock Down 0.1%
Shares of NYSE AMRZ opened at $56.26 on Friday. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $56.43. The company has a market capitalization of $31.11 billion and a PE ratio of 30.57. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. The stock’s fifty day moving average price is $50.18.
Amrize (NYSE:AMRZ – Get Free Report) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $0.98 EPS for the quarter, missing the consensus estimate of $1.01 by ($0.03). The company had revenue of $3.68 billion during the quarter, compared to analyst estimates of $3.49 billion. The business’s quarterly revenue was up 6.6% on a year-over-year basis.
Amrize Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
See Also
- Five stocks we like better than Amrize
- What is the Nasdaq? Complete Overview with History
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- Dividend Payout Ratio Calculator
- The Best Holiday Present You Can Give Yourself? Costco Stock
- What Investors Need to Know About Upcoming IPOs
- Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
